[HTML] plos.org

[HTML][HTML] Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - PloS one, 2008 - journals.plos.org
Background The objective was to evaluate the safety, reactogenicity and immunogenicity of
the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to …
被引用次数：133 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - 2008 - pdfs.semanticscholar.org
Background. The objective was to evaluate the safety, reactogenicity and immunogenicity of
the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to …

[引用][C] Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - PLoS …, 2008 - ui.adsabs.harvard.edu
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase
1 Randomized Controlled Trial - NASA/ADS Now on home page ads icon ads Enable full ADS …
[PDF] academia.edu

[PDF][PDF] Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - 2008 - academia.edu
Background. The objective was to evaluate the safety, reactogenicity and immunogenicity of
the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to …

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - PloS …, 2008 - pubmed.ncbi.nlm.nih.gov
Background The objective was to evaluate the safety, reactogenicity and immunogenicity of
the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to …

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - PLOS …, 2008 - econpapers.repec.org
Background: The objective was to evaluate the safety, reactogenicity and immunogenicity of
the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to …

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - PLoS ONE, 2008 - go.gale.com
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase
1 Randomized Controlled Trial - Document - Gale OneFile: Health and Medicine Use this link …
[PDF] researchgate.net

[PDF][PDF] Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - 2008 - researchgate.net
Background. The objective was to evaluate the safety, reactogenicity and immunogenicity of
the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to …

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: Results of a phase 1 randomized controlled trial

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - PLoS …, 2008 - researchers.cdu.edu.au
Background. The objective was to evaluate the safety, reactogenicity and immunogenicity of
the AMA-1-based blood-stage malaria vaccine FMP2. 1/AS02A in adults exposed to …

Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.

MA Thera, OK Doumbo, D Coulibaly, DA Diallo… - Plos one, 2008 - europepmc.org
Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1
randomized controlled trial. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …